共 108 条
[1]
Rosenheck R(2003)Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial JAMA 290 2693-2702
[2]
Perlick D(2003)Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and Whites in the United States Arch Gen Psychiatry 60 121-128
[3]
Bingham S(2004)Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs Pharmacoeconomics 22 1-8
[4]
Daumit GL(1997)Pharmacoeconomic evaluation of antipsychotic therapy for schizophrenia J Clin Psychiatry 58 50-54
[5]
Crum RM(1999)Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia: results from a randomised clinical trial Pharmacoeconomics 15 469-480
[6]
Guallar E(2004)Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia: an economic perspective Pharmacoeconomics 22 701-718
[7]
Tunis SL(2001)Symptom effects on employment in a structural model of mental illness and treatment: analysis of patients with schizophrenia J Ment Health Policy Econ 4 25-34
[8]
Ascher-Svanum H(2003)Employment retention by persons with schizophrenia employed in non-assisted jobs J Rehabilitation 69 18-25
[9]
Stensland M(2004)Gender-specific patterns of employment and employment transitions for persons with schizophrenia: evidence from the Schizophrenia Care and Assessment Program (SCAP) Research in human capital and development: the economics of gender and mental illness 15 109-131
[10]
Glazer WM(2000)Atypical antipsychotics BMJ 321 1360-1361